Literature DB >> 11114332

The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes.

D F Robbiani1, R A Finch, D Jäger, W A Muller, A C Sartorelli, G J Randolph.   

Abstract

Adaptive immune responses begin after antigen-bearing dendritic cells (DCs) traffic from peripheral tissues to lymph nodes. Here, we show that DC migration from skin to lymph nodes utilizes the leukotriene C(4) (LTC(4)) transporter multidrug resistance-associated protein 1 (MRP1). DC mobilization from the epidermis and trafficking into lymphatic vessels was greatly reduced in MRP1(-/-) mice, but migration was restored by exogenous cysteinyl leukotrienes LTC(4) or LTD(4). In vitro, these cysteinyl leukotrienes promoted optimal chemotaxis to the chemokine CCL19, but not to other related chemokines. Antagonism of CCL19 in vivo prevented DC migration out of the epidermis. Thus, MRP-1 regulates DC migration to lymph nodes, apparently by transporting LTC(4), which in turn promotes chemotaxis to CCL19 and mobilization of DCs from the epidermis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114332     DOI: 10.1016/s0092-8674(00)00179-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  119 in total

1.  Irritancy and allergic responses induced by exposure to the indoor air chemical 4-oxopentanal.

Authors:  Stacey E Anderson; Jennifer Franko; Laurel G Jackson; J R Wells; Jason E Ham; B J Meade
Journal:  Toxicol Sci       Date:  2012-03-08       Impact factor: 4.849

Review 2.  The organization and consequences of eicosanoid signaling.

Authors:  Roy J Soberman; Peter Christmas
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 3.  Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances.

Authors:  Gwendalyn J Randolph; Guzman Sanchez-Schmitz; Veronique Angeli
Journal:  Springer Semin Immunopathol       Date:  2005-01

4.  The membrane organization of leukotriene synthesis.

Authors:  Asim K Mandal; Jesse Skoch; Brian J Bacskai; Bradley T Hyman; Peter Christmas; Douglas Miller; Ting-ting D Yamin; Shihua Xu; Douglas Wisniewski; Jilly F Evans; Roy J Soberman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

5.  Slowing down with age: lung DCs do it too.

Authors:  Thomas J Braciale; Taeg S Kim
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

6.  IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression.

Authors:  R Spanbroek; M Hildner; A Köhler; A Müller; F Zintl; H Kühn; O Rådmark; B Samuelsson; A J Habenicht
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

7.  Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations.

Authors:  Susanna L Lundström; Rohit Saluja; Mikael Adner; Jesper Z Haeggström; Gunnar Nilsson; Craig E Wheelock
Journal:  J Lipid Res       Date:  2012-10-03       Impact factor: 5.922

8.  Collecting lymphatic vessel permeability facilitates adipose tissue inflammation and distribution of antigen to lymph node-homing adipose tissue dendritic cells.

Authors:  Emma L Kuan; Stoyan Ivanov; Eric A Bridenbaugh; Gabriel Victora; Wei Wang; Ed W Childs; Andrew M Platt; Claudia V Jakubzick; Robert J Mason; Anatoliy A Gashev; Michel Nussenzweig; Melody A Swartz; Michael L Dustin; David C Zawieja; Gwendalyn J Randolph
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

9.  Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes.

Authors:  Brigid Joseph; Kuldeep K Bhargava; Harmeet Malhi; Michael L Schilsky; Diwakar Jain; Christopher J Palestro; Sanjeev Gupta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-21       Impact factor: 9.236

Review 10.  A two-step model for Langerhans cell migration to skin-draining LN.

Authors:  Eduardo J Villablanca; Jorge R Mora
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.